ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) was the recipient of a significant growth in short interest in the month of April. As of April 30th, there was short interest totalling 12,030,000 shares, a growth of 7.8% from the April 15th total of 11,160,000 shares. Based on an average daily trading volume, of 1,810,000 […]
Brokers Issue Forecasts for ACADIA Pharmaceuticals Inc.'s FY2026 Earnings (NASDAQ:ACAD) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
M&G Investment Management Ltd. Acquires New Stake in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) to Post Q2 2024 Earnings of $0.09 Per Share, Leerink Partnrs Forecasts dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
ACADIA Pharmaceuticals (NASDAQ:ACAD) Issues Earnings Results themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.